bendamustine hydrochloride has been researched along with Cognition Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, FT; Bloch, W; Elter, T; Fiebig, L; Hahn, M; Hallek, M; Hülsdünker, T; Mierau, A; Reinart, N; Schenk, A; Strüder, HK; Zimmer, P | 1 |
1 other study(ies) available for bendamustine hydrochloride and Cognition Disorders
Article | Year |
---|---|
Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab a
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bendamustine Hydrochloride; Brain-Derived Neurotrophic Factor; Cognition Disorders; Cyclophosphamide; Doxorubicin; Electroencephalography; Fatigue; Female; Humans; Interleukin-6; Lymphoma, Non-Hodgkin; Male; Middle Aged; Outcome Assessment, Health Care; Prednisone; Rituximab; Surveys and Questionnaires; Vincristine | 2015 |